Expands library of proprietary cannabinoid analogs for pharma R&D Research collaboration initiated to screen analogs for therapeutic uses VANCOUVER, BC & SOUTH SAN FRANCISCO, CA. — InMed Pharmaceuticals Inc. (“InMed” or… Read More
VANCOUVER, BC & SEATTLE– Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing next-generation multifunctional biotherapeutics, today announced that it has completed enrollment in its global HERIZON-BTC-01 pivotal clinical trial… Read More
In the quest to build smart skin that mimics the sensing capabilities of natural skin, ionic skins have shown significant advantages. They’re made of flexible, biocompatible hydrogels that use ions… Read More
VANCOUVER, B.C. – BC Children’s Hospital Foundation today announced the launch of new stem cell research technology at BC Children’s Hospital (“BC Children’s”), which for the first time in history… Read More
University of British Columbia researchers have found a ‘silver bullet’ to kill bacteria and keep them from infecting patients who have medical devices implanted. The team from UBC and the Vancouver… Read More
